N-3 Polyunsaturated Fatty Acids ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04761952
(ClinicalTrials.gov)
February 13, 202114/2/2021N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's DiseaseN-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease:a Prospective Randomized Controlled TrialInflammatory Bowel Diseases;Crohn Disease;Polyunsaturated Acid LipidosisDrug: azathioprine;Drug: infliximab;Drug: N-3 Polyunsaturated Fatty AcidsSixth Affiliated Hospital, Sun Yat-sen UniversityNULLNot yet recruiting18 Years80 YearsAll236N/ANULL